HAVCR2 and acute myeloid leukemia: Additionally, other than tetramer, immune checkpoints (such as PD-1, TIM3, and 4-1BB), the stem-cell-like marker CD39, and the cytokines mentioned above can also be employed to broaden the screening of neoantigen-specific T-cell for AML (Fig. 1).